Dana-Farber/Boston Children's Ranked Among the Best Pediatric Cancer Programs in the Nation for 18th Year in a Row
Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia
Dana-Farber Cancer Institute Leads the Launch of IGNITE Consortium to Eradicate Health Inequities in Pediatric Cancer Care
Prostate Cancer Vaccines: What’s the Latest?
Researchers Uncover Key Actor in Spread of Breast Cancer to the Brain
High-Dose Vitamin D3 Does Not Provide Benefit for Metastatic Colorectal Cancer
Breast Cancer Research: New Studies Show How Post-Treatment Lifestyle Choices Shape Long-Term Outcomes After Diagnosis
Long-term Metastatic Melanoma Survival Dramatically Improves on Immunotherapy
Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer
Comprehensive Cancer Research from Dana-Farber Leads ESMO Congress 2024
Powerful New Mini Microscopic Will Enable Precision Cancer Surgery
Pancreatic Cancer: Study Finds Most Early Staging Inaccurate
Adolescent Glioma Subtype Responds to CDK4/6 Inhibitor
Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation
Showing 1 - 15 of 1020 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...68 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
